The intricate cellular environment relies on motor proteins like dynein to transport essential cargo within cells, especially toward the nucleus for proper cell function.
The protein Lis1 plays a vital role in regulating dynein activity, with disruptions in this process linked to severe neurodevelopmental disorders such as lissencephaly.
Recent groundbreaking research by teams at the Salk Institute and UC San Diego captured high-resolution movies showing the stepwise activation of dynein by Lis1.
Dynein is a large protein complex with motor domains that allow it to move along microtubule tracks by hydrolyzing ATP.
Previous studies hinted at Lis1 unlocking dynein from an inactive state, termed the Phi state, but the new research provides dynamic insights using cryo-EM imaging.
The study revealed a multi-step activation process where Lis1 binds to dynein's motor domain, prompting shape changes that enhance ATP hydrolysis efficiency and motor activity.
Understanding dynein activation is crucial for addressing neurological disorders like lissencephaly, and these findings pave the way for potential drug design to restore motor function.
The high-resolution data also offer insights for developing precision medicines targeting the dynein-Lis1 complex, with implications for treating a range of neurological diseases.
Future research will focus on dissecting how mutations in Lis1 or dynein contribute to disease and validating therapeutic strategies using human proteins and neuronal cell models.
Structural biology techniques like cryo-EM allow researchers to visualize molecular events in real-time, accelerating the discovery of treatments for diseases associated with protein dysfunction.
The collaborative research was supported by prestigious funding bodies and underscores the importance of interdisciplinary collaboration in advancing biomedical science at institutions like the Salk Institute.